Material
Conference on Drug Development for the Third World | (smr 1755)
Go to day
-
-
08:00 - 08:50
REGISTRATION FOR ALL PARTICIPANTS
- 08:00 REGISTRATION FOR ALL PARTICIPANTS 50'
-
08:50 - 10:40
SESSION 1.1. Welcome!! and Introduction to the Challenges and Opportunities
-
08:50
SESSION 1.1. Welcome!! and Introduction to the Challenges and Opportunities
1h50'
-
08:50
SESSION 1.1. Welcome!! and Introduction to the Challenges and Opportunities
1h50'
-
10:40 - 11:10
Break
- 10:40 Break 30'
-
11:10 - 12:30
SESSION 1.2. Drug Action at the Atomic Level
-
11:10
SESSION 1.2. Drug Action at the Atomic Level
1h20'
-
11:10
SESSION 1.2. Drug Action at the Atomic Level
1h20'
-
12:30 - 13:40
Lunch
- 12:30 Lunch 1h10'
-
13:40 - 14:20
SESSION 1.3 Medicinal Chemistry and Drug Discovery
-
13:40
SESSION 1.3 Medicinal Chemistry and Drug Discovery
40'
-
13:40
SESSION 1.3 Medicinal Chemistry and Drug Discovery
40'
-
14:20 - 15:00
SESSION 1.4 Computation in Drug Design
-
14:20
SESSION 1.4 Computation in Drug Design
40'
-
14:20
SESSION 1.4 Computation in Drug Design
40'
-
15:00 - 15:30
Break
- 15:00 Break 30'
-
15:30 - 16:40
SESSION 1.5 Demos on Computation in Drug Design
-
15:30
SESSION 1.5 Demos on Computation in Drug Design
1h10'
-
15:30
SESSION 1.5 Demos on Computation in Drug Design
1h10'
-
08:00 - 08:50
REGISTRATION FOR ALL PARTICIPANTS
-
-
08:30 - 10:10
SESSION 2.1 : Challenges and Opportunities
-
08:30
SESSION 2.1 : Challenges and Opportunities
1h40'
-
08:30
SESSION 2.1 : Challenges and Opportunities
1h40'
-
10:10 - 10:40
Break
- 10:10 Break 30'
-
10:40 - 12:10
SESSION 2.2 Drug Action at the Atomic Level
-
10:40
SESSION 2.2 Drug Action at the Atomic Level
1h30'
-
10:40
SESSION 2.2 Drug Action at the Atomic Level
1h30'
-
12:10 - 13:30
Lunch
- 12:10 Lunch 1h20'
-
13:30 - 15:00
SESSION 2.3 Medicinal Chemistry and Drug Discovery
-
13:30
SESSION 2.3 Medicinal Chemistry and Drug Discovery
1h30'
-
13:30
SESSION 2.3 Medicinal Chemistry and Drug Discovery
1h30'
-
15:00 - 15:30
Break
- 15:00 Break 30'
-
15:30 - 16:30
SESSION 2.4 Computation in Drug Design
-
15:30
SESSION 2.4 Computation in Drug Design
1h0'
-
15:30
SESSION 2.4 Computation in Drug Design
1h0'
-
16:30 - 17:40
SESSION 2.5 Bioinformatics for Drug Design
-
16:30
SESSION 2.5 Bioinformatics for Drug Design
1h10'
-
16:30
SESSION 2.5 Bioinformatics for Drug Design
1h10'
-
08:30 - 10:10
SESSION 2.1 : Challenges and Opportunities
-
-
08:30 - 09:40
SESSION 3.1 : Challenges and Opportunities
-
08:30
SESSION 3.1 : Challenges and Opportunities
1h10'
-
08:30
SESSION 3.1 : Challenges and Opportunities
1h10'
-
10:10 - 10:40
Break
- 10:10 Break 30'
-
10:40 - 11:20
SESSION 3.2 Drug Targeting at the Molecular Level
-
10:40
SESSION 3.2 Drug Targeting at the Molecular Level
40'
-
10:40
SESSION 3.2 Drug Targeting at the Molecular Level
40'
-
11:20 - 12:00
SESSION 3.3 Medicinal Chemistry and Drug Discovery
-
11:20
SESSION 3.3 Medicinal Chemistry and Drug Discovery
40'
-
11:20
SESSION 3.3 Medicinal Chemistry and Drug Discovery
40'
-
12:00 - 13:10
Lunch
- 12:00 Lunch 1h10'
-
13:10 - 15:00
SESSION 3.4 Bioinformatics and Computational Chemistry for Drug Design
Location: Adriatico Guest House - Eklund Informatics Lab (Lower Level 1) -
13:10
SESSION 3.4 Bioinformatics and Computational Chemistry for Drug Design
1h50'
-
13:10
SESSION 3.4 Bioinformatics and Computational Chemistry for Drug Design
1h50'
-
15:00 - 15:30
Break
- 15:00 Break 30'
-
15:30 - 16:40
Ligand docking Lab
Location: Adriatico Guest House - Eklund Informatics Lab (Lower Level 1) -
15:30
Ligand docking Lab
1h10'
Speaker: F. Herrera and K. Khafizof (International School for Advanced Studies, Trieste)
-
15:30
Ligand docking Lab
1h10'
-
16:40 - 17:40
Electrostatic modelling Lab
Location: Adriatico Guest House - Eklund Informatics Lab (Lower Level 1) -
16:40
Electrostatic modelling Lab
1h0'
Speaker: A. Magistrato and S. Raugei (International School for Advanced Studies, Trieste) Material: Tutorial
-
16:40
Electrostatic modelling Lab
1h0'
-
08:30 - 09:40
SESSION 3.1 : Challenges and Opportunities
-
-
08:30 - 10:10
SESSION 4.1 : Challenges and Opportunities
-
08:30
SESSION 4.1 : Challenges and Opportunities
1h40'
-
08:30
SESSION 4.1 : Challenges and Opportunities
1h40'
-
10:10 - 10:40
Break
- 10:10 Break 30'
-
10:40 - 12:15
SESSION 4.2 Drug and Vaccine Design at the Atomic Level
-
10:40
SESSION 4.2 Drug and Vaccine Design at the Atomic Level
1h35'
-
10:40
SESSION 4.2 Drug and Vaccine Design at the Atomic Level
1h35'
-
12:15 - 13:35
Lunch
- 12:15 Lunch 1h20'
-
13:30 - 15:00
SESSION 4.3 Medicinal Chemistry and Drug Discovery
-
13:30
SESSION 4.3 Medicinal Chemistry and Drug Discovery
1h30'
-
13:30
SESSION 4.3 Medicinal Chemistry and Drug Discovery
1h30'
-
15:00 - 15:30
Break
- 15:00 Break 30'
-
15:30 - 16:50
SESSION 4.4 Computation in Drug Design
-
15:30
SESSION 4.4 Computation in Drug Design
1h20'
-
15:30
SESSION 4.4 Computation in Drug Design
1h20'
-
08:30 - 10:10
SESSION 4.1 : Challenges and Opportunities
-
-
08:30 - 10:10
SESSION 5.1 : Challenges and Opportunities
-
08:30
SESSION 5.1 : Challenges and Opportunities
1h40'
-
08:30
SESSION 5.1 : Challenges and Opportunities
1h40'
-
10:10 - 10:40
Break
- 10:10 Break 30'
-
10:40 - 12:10
SESSION 5. 2 Drug Design at the Atomic Level
-
10:40
SESSION 5. 2 Drug Design at the Atomic Level
1h30'
-
10:40
SESSION 5. 2 Drug Design at the Atomic Level
1h30'
-
12:10 - 13:30
Lunch
- 12:10 Lunch 1h20'
-
13:30 - 14:30
SESSION 5.3 Computation in Drug Design
-
13:30
SESSION 5.3 Computation in Drug Design
1h0'
-
13:30
SESSION 5.3 Computation in Drug Design
1h0'
-
14:30 - 14:30
Meeting adjourns; students can continue working with computers
- 14:30 Meeting adjourns; students can continue working with computers
-
08:30 - 10:10
SESSION 5.1 : Challenges and Opportunities